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Background: Frailty is a multidimensional syndrome characterized by loss of physiologic and cognitive reserve that
heightens vulnerability. Frailty has been well described among elderly patients (i.e., 65 years of age or older), but
few studies have evaluated frailty in nonelderly patients with critical illness. We aimed to describe the prevalence,
correlates, and outcomes associated with frailty among younger critically ill patients.
Methods: We conducted a prospective cohort study of 197 consecutive critically ill patients aged 50–64.9 years
admitted to intensive care units (ICUs) at six hospitals across Alberta, Canada. Frailty was defined as a score ≥5 on
the Clinical Frailty Scale before hospitalization. Multivariable analyses were used to evaluate factors independently
associated with frailty before ICU admission and the independent association between frailty and outcome.
Results: In the 197 patients in the study, mean (SD) age was 58.5 (4.1) years, 37 % were female, 73 % had three or
more comorbid illnesses, and 28 % (n = 55; 95 % CI 22–35) were frail. Factors independently associated with frailty
included not being completely independent (adjusted OR [aOR] 4.4, 95 % CI 1.8–11.1), connective tissue disease
(aOR 6.0, 95 % CI 2.1–17.0), and hospitalization within the preceding year (aOR 3.3, 95 % CI 1.3–8.1). There were no
significant differences between frail and nonfrail patients in reason for admission, Acute Physiology and Chronic
Health Evaluation II score, preference for life support, or treatment intensity. Younger frail patients did not have
significantly longer (median [interquartile range]) hospital stay (26 [9–68] days vs. 19 [10–43] days; p = 0.4), but they
had greater 1-year rehospitalization rates (61 % vs. 40 %; p = 0.02) and higher 1-year mortality (33 % vs. 20 %;
adjusted HR 1.8, 95 % CI 1.0–3.3; p = 0.039).
Conclusions: Prehospital frailty is common among younger critically ill patients, and in this study it was associated
with higher rates of mortality at 1 year and with rehospitalization. Our data suggest that frailty should be
considered in younger adults admitted to the ICU, not just in the elderly. Additional research is needed to further
characterize frailty in younger critically ill patients, along with the ideal instruments for identification.
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Frailty is a multidimensional syndrome characterized by
a decline in physiologic and cognitive homeostatic
reserve that increases susceptibility to adverse events
and unfavorable outcomes, often following relatively
minor stressors [1]. Frailty is causally related to aging,
has been conventionally described in elderly populations,
and characterizes a common trajectory at the end of life* Correspondence: bagshaw@ualberta.ca
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(http://creativecommons.org/publicdomain/ze[2–5]. Frail persons show greater risk for procedural
complications, disability, impaired health-related quality
of life (HRQoL), hospitalizations, institutionalization,
and death [6–10].
Recent data show that frailty is common among
patients admitted to intensive care units (ICUs) [11, 12].
Premorbid frailty appears to be an independent (and
potentially modifiable) factor associated with less favorable
outcomes and greater health services use [13–15].
However, most studies have been focused exclusively on
describing frailty among older populations (i.e., ≥65 years
of age); in fact, frailty has rarely been considered to occurle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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frailty in the Canadian general population among
persons aged 40–69 years is estimated at <10 %; how-
ever, when present, it portends greater health service
use and mortality risk [17].
We hypothesized frail patients may have greater
susceptibility to developing critical illness and that their
risk may be “age-shifted” compared with nonfrail
patients of similar chronologic age. Consequently, the
prevalence of frailty may be higher than expected for
chronologic age among a cohort of younger patients
admitted to the ICU [17]. Previously, we performed a
prospective multicenter study in a cohort of critically ill
patients to describe the association between frailty and
outcomes [11]. In this substudy, we aimed to specifically
examine the prevalence, correlates, and outcomes associ-
ated with frailty in a younger cohort of critically ill
patients (i.e., age at ICU admission 50–64.9 years), in
whom it has rarely been described.
Methods
Study design, participants and setting
We conducted a planned substudy of a prospective
multicenter cohort study that has been described previ-
ously [11]. Adults admitted to six closed multisystem
medical-surgical ICUs located in two tertiary/academic
and four community hospitals in Alberta, Canada,
between February 2010 and July 2011 were screened for
enrollment [11]. The study was approved by the research
ethics board at the University of Alberta (Pro00007628).
All participants or their designated surrogate decision-
makers provided written informed consent to participate.
Frailty definition
Frailty was operationalized using the Canadian Study of
Health and Aging Clinical Frailty Scale (CFS) score,
which was modified to an 8-point tool designed to
categorize patients as fit, vulnerable, or frail [6]. The
CFS is a subjective judgment-based screening tool for
frailty that has been proven to be valid, reliable, and sim-
ple to perform. We defined patients as frail if their CFS
score was ≥5 (moderate to severe frailty for CFS score 6–8),
as vulnerable if their CFS score was 4, and as fit if their CFS
score was ≤3 [11]. Trained coordinators interviewed partici-
pants and/or their surrogate decision-makers and reviewed
each participant’s medical record.
Outcomes
The primary outcome was all-cause mortality 1 year
following enrollment. Secondary outcomes were focused
on (1) patient-centered outcomes, including ICU,
hospital, 90-day, and 6-month mortality; HRQoL at 6
and at 12 months, captured using the EuroQol (EQ-5D)
Health Questionnaire (including the EQ-5D visualanalogue scale [EQ-5D-VAS]) [13]; and discharge dispos-
ition; and (2) health service use, including ICU and hospital
lengths of stay, ICU readmission, and hospital readmission
in the 1-year period following enrollment.
Data collection and management
Data were prospectively captured on standardized forms
and entered into an electronic database. These data
elements included sociodemographic factors, baseline
functional status and disability (e.g., basic and instru-
mental activities of daily living), comorbid conditions
defined and summated using the Elixhauser comorbidity
scale [18], prescription medications, source of ICU
admission (e.g., ward, operating theater, emergency
department), diagnostic category, illness severity (e.g.,
defined according to the Acute Physiology and Chronic
Health Evaluation [APACHE] II score [19]), presence
and severity of organ dysfunction (e.g., defined according
to the Sequential Organ Failure Assessment score [20]),
treatment intensity (e.g., mechanical ventilation, vasoactive
support, renal replacement therapy), and preferences for
life-sustaining therapy (e.g., full ICU support, limitation in
therapy). Participants were contacted at 6 and 12 months
to ascertain long-term outcomes, including vital status,
disposition, and HRQoL.
Statistical analyses
Among nonelderly patients, the distribution of CFS scores
was presented and descriptive statistics were calculated
according to the presence or absence of frailty. Independ-
ent associations between baseline sociodemographic and
clinical characteristics as well as frailty status were
evaluated using multivariable logistic regression analysis.
Clinically important variables (i.e., sex, comorbidity, case
mix, APACHE II score, site) and those found to be signifi-
cant in univariate analysis (p = 0.20) were entered into the
multivariable model. Model calibration and discrimination
were assessed using the Hosmer-Lemeshow goodness-of-
fit test, Brier score, and the AUC (c-statistic). The
independent percentage contribution of each variable in
the model’s explanatory power was estimated by dividing
differences in log-likelihoods of the nested models by the
difference in the log-likelihoods of null and full (final)
models [14, 21]. Sensitivity analysis was performed by
adding the variables age, surgical status, and sepsis to the
multivariable model. Survival curves were plotted using
Kaplan-Meier curves with log-rank tests. Multivariable
Cox proportional hazards regression analyses were
performed to analyze survival. Similar to the analyses
described above, clinically important variables (i.e., sex,
comorbidity, case mix, APACHE II score, site) and those
found to be significant in univariate analysis (p = 0.20)
were entered into the multivariable model. Proportional
hazards model assumptions were checked by comparing
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and nonfrail patients and testing interactions between
frailty status and logarithmic scales of follow-up times in
the model. A p value <0.05 was considered statistically sig-
nificant for all comparisons. All analyses were performed
using STATA 12.1 software (StataCorp, College Station,
TX, USA).
Results
Overall, 197 patients (47 % of the study cohort) aged
50–64.9 years were included in this substudy (Add-
itional files 1 and 2). The mean (SD) age was 58.5
(4.1) years, 37 % (n = 72) were female, 73 % (n = 143)
had three or more comorbid illnesses, 74 % (n = 146)
were living at home independently, and 41 % (n =
80) had been hospitalized in the preceding 1-year
period. The median (interquartile range) prehospital
CFS score was 4 (3–5). Of the cohort, 39 % (95 %
CI 32–46; n = 76) were classified as fit, 34 % (95 %
CI 27–41 %; n = 66) were classified as vulnerable,
and 28 % (95 % CI 22–35 %; n = 55) were classified
as frail (CFS score ≥5) (Fig. 1).Factors associated with frailty among nonelderly patients
There were numerous differences in baseline sociode-
mographic and clinical characteristics among frail and
nonfrail patients (Table 1). Several factors were found
in multivariable analysis to be independently associated
with prehospital frailty, including prehospital residence,
receipt of disability insurance, prior hospitalization,
female sex, and comorbid connective tissue disease
(CTD) (Table 2). These five variables represented
89 % of the final model’s explanatory power for pre-
hospital frailty.Fig. 1 Summary of prevalence of Clinical Frailty Scale (CFS) scores, stratifiedAssociation between frailty and clinical course among
nonelderly patients
Other than postoperative status (which was less com-
mon among frail patients), there were no significant dif-
ferences in diagnostic category, admission source,
treatment intensity or patient preferences for life-
sustaining therapy between frail and not frail (Table 3).Association between frailty and mortality among
nonelderly patients
Unadjusted mortality at 1 year was not significantly
greater for frail patients than for nonfrail patients (32.7 %
vs. 20.4 %; OR 1.90, 95 % CI 0.95–3.78). Unadjusted
mortality in the ICU, in the hospital, at 90 days, and at
6 months was similarly not statistically different between
frail and nonfrail patients (Table 3). In multivariable
analysis, frail patients were found to have a higher
adjusted risk of death at 1 year than nonfrail patients
(adjusted HR 1.83, 95 % CI 1.03–3.25; p = 0.039)
(Fig. 2 and Fig. 3). The burden of comorbid illness,
acute illness severity, and frailty represented 81 % of
the model’s final explanatory power for 1-year mortal-
ity. There was evidence of a dose-response increase in
adjusted risk of death associated with greater CFS
score (Table 4 and Fig. 4). This increase was most ap-
parent when we compared fit (CFS score 1–3) with
moderate to severe frailty (CFS score 6–8), while
there was overlap among those classified as vulner-
able (CFS score 4) and mildly frail (CFS score 5). In
an exploratory analysis using the entire study cohort
(n = 421), there was an effect modification between
frailty and age with respect to all-cause mortality
(mortality among frail patients age <65 years 36 % vs. age
≥65 years 59 %; OR 2.0,3 95 % CI 1.30–3.16; p < 0.001),by age older or younger than 65 years
Table 1 Baseline sociodemographic, clinical, and comorbidity
data for patients younger than 65 years old admitted to the








Age, years, mean ± SD 58.9 ± 4.1 58.4 ± 4.2 0.444
Sex, female, n (%) 28 (50.9) 44 (31.0) 0.009
Widowed, n (%) 4 (7.3) 7 (4.9) 0.504
Education, n (%) 0.039
Less than secondary school 14 (25.5) 17 (12.0)
Secondary school 23 (41.8) 58 (40.8)
Higher-level degree 18 (32.7) 67 (47.2)
Employment status, n (%)
Full-time 9 (16.4) 50 (35.2) 0.010
Part-time 1 (1.8) 15 (10.6) 0.045
On disability 28 (50.9) 31 (21.8) <0.001
Prehospital residence, n (%) <0.001
At home (independent) 23 (41.8) 123 (86.6)
At home (with help) 26 (47.3) 18 (12.7)
Other 6 (10.9) 1 (0.7)
CSHA Function Scale score (n, %)
Eating (independent) 51 (92.7) 142 (100) 0.006
Dressing (independent) 47 (85.5) 141 (99.3) <0.001
Personal care (independent) 45 (81.8) 142 (100) <0.001
Walking (independent) 35 (63.6) 134 (94.4) <0.001
Getting out of bed (independent) 40 (72.7) 141 (99.3) <0.001
Taking bath (independent) 37 (67.3) 140 (98.6) <0.001
Using toilet (independent) 49 (89.1) 140 (98.6) 0.007
Using telephone (independent) 52 (94.5) 142 (100) 0.021
Going shopping (independent) 25 (45.5) 133 (93.7) <0.001
Preparing own meals (independent) 29 (52.7) 138 (97.2) <0.001
Doing housework (independent) 26 (47.3) 132 (93.0) <0.001
Taking medicine (independent) 40 (72.7) 133 (93.7) <0.001
Managing own finances (independent) 46 (83.6) 138 (97.2) 0.002
Elixhauser comorbidity score, mean ± SD 8.7 ± 9.1 6.6 ± 7.6 0.098
Hypertension 26 (47.3) 73 (51.4) 0.602
Heart failure 10 (18.2) 9 (6.3) 0.012
Diabetes mellitus 18 (32.7) 31 (21.8) 0.112
Chronic kidney disease 13 (23.6) 23 (16.2) 0.225
Rheumatoid/connective tissue disease 20 (36.4) 13 (9.2) <0.001
Any cancer 5 (9.1) 16 (11.3) 0.657
Alcohol/drug abuse 16 (29.1) 50 (35.2) 0.414
Psychosis 3 (5.5) 4 (2.8) 0.401
Depression 18 (32.7) 38 (26.8) 0.405
Prescription medications, n, mean ± SD 8.8 ± 6.2 5.1 ± 4.3 <0.001
Hospitalization in preceding
1-year period, mean ± SD
34 (61.8) 46 (32.4) <0.001
CSHA Canadian Study on Health and Aging
Table 2 Multivariable analysis of factors associated with
prehospital frailty among patients younger than 65 years old
Variable Adjusted OR
(95 % CI)
p Value % contribution
Sex 3.8
Male 1
Female 2.01 (0.87–4.66) 0.103
Elixhauser comorbidity score,
mean ± SD
0.96 (0.91–1.02) 0.213 1.6
Rheumatoid/CTD 6.00 (2.12–17.0) 0.001 19.7
Heart failure 3.28 (0.78–13.7) 0.104 1.8
Prehospital residence 49.3
At home (independent) 1
At home (with help)/other 4.40 (1.75–11.1) 0.002
On disability 2.11 (0.83–5.35) 0.117 4.1
Managing own finances
(independent)
0.24 (0.05–1.24) 0.088 3.5
Never married 0.23 (0.03–1.56) 0.133 2.8
Education 1.7
Less than high school 1
High school 0.76 (0.23–2.50) 0.653
Higher-level degree 0.53 (0.16–1.75) 0.296
Prescription medications, n,
mean ± SD
1.01 (0.93–1.10) 0.748 0.1
Prior hospitalization 3.29 (1.34–8.10) 0.010 11.7
CTD connective tissue disease
The overall model is significant (likelihood ratio χ12
2 = 78.73 with p < 0.0001)
with good discriminatory ability (c-statistic 0.85) and goodness of fit
(calibration, Brier score 0.12; Hosmer-Lemeshow χ8
2 = 10.37 with p = 0.24).
In sensitivity analyses, age, surgical status, and sepsis were also included in the
multivariable model. These did not translate into significant changes across
any covariates or percentage contribution to the model.
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was not statistically significant (OR 0.84, 95 % CI 0.42–
1.71; p = 0.68) (Additional file 3).
Association between frailty and nonfatal outcomes
among nonelderly patients
Among hospital survivors, 69.8 % of frail and 76.2 % of
nonfrail patients were living at home (difference 6.4 %,
95 % CI −9.9 % to 22.1 %); however, only 32.8 % of frail
patients were independent (absolute decrease from
prehospital level −9.2 %, 95 % CI −28.4 % to 9.9 %),
while 50.8 % of nonfrail patients were independent
(absolute decrease from prehospital −35.8 %, 95 % CI
−46.3 % to −25.3 %) at the time of hospital discharge.
EQ-5D-VAS scores were similar for frail and nonfrail
patients at 6 months (58.8 [18.7] vs. 63.4 [20.4]; p = 0.25)
and at 12 months (63.0 [20.2] vs. 68.3 [17.6]; p = 0.18).
There was no significant difference between 6 and
12 months in the EQ-5D-VAS for frail and nonfrail
patients (4.0 [95 % CI −1.4 to 9.5] vs. 5.3 [95 % CI 1.8–
8.8]; p = 0.72) or in the proportion achieving a minimal
Table 3 Summary of case mix, clinical course, and outcomes for
critically ill patients younger than 65 years old, stratified by frailty
status




Sepsis 10 (18.2) 15 (10.6)
Cardiovascular 5 (9.1) 20 (14.1)
Respiratory 22 (40.0) 45 (31.7)
Gastrointestinal/liver 9 (16.4) 25 (17.6)
Othera 9 (16.4) 37 (26.1)
ICU admission source, n (%) 0.900
Ward transfer 17 (30.9) 41 (28.9)
OR theater transfer 13 (23.6) 39 (27.5)
ED 14 (25.5) 40 (28.1)
Otherb 10 (18.2), 1 (1.8) 20 (14.1), 2 (1.4)
Postoperative, n (%) 13 (23.6) 55 (38.7) 0.046
APACHE II score, mean ± SD 19.8 ± 6.7 17.9 ± 7.4 0.103
SOFA score, mean ± SD 8.2 ± 4.0 7.0 ± 4.1 0.086
Mechanical ventilation, n (%) 52 (94.5) 120 (84.5) 0.058
Vasoactive medications, n (%) 33 (60.0) 72 (50.7) 0.241
Renal replacement therapy,
n (%)
6 (10.9) 21 (14.8) 0.478
Preferences for support, n (%) 0.069
Full ICU support 48 (87.3) 134 (95.0)
Limitations on therapy
(DNR order)
7 (12.7) 7 (5.0)
Mortality, n (%)
ICU 6 (10.9) 10 (7.0) 0.390
Hospital 11 (20.0) 20 (14.1) 0.306
90-day 13 (23.6) 21 (14.8) 0.140
6-month 16 (29.1) 25 (17.6) 0.075
1-year 18 (32.7) 29 (20.4) 0.069
ICU length of stay, days,
median (IQR)
6 (3.5–11.5) 6 (3–10) 0.383
ICU readmission, n (%) 9 (18.4) 18 (13.6) 0.427
Hospital length of stay,
median (IQR)
26 (9–68) 18.5 (10–43) 0.389
Hospital readmission, n (%) 26 (60.5) 49 (40.2) 0.022
Discharge disposition, n (%) 0.112
Living at home independent 14 (32.6) 62 (50.8)
Living at home with help 16 (37.2) 31 (25.4)
Other 13 (30.2) 29 (23.8)
EQ-5D-VAS, 6-month
Mean (SD) 58.8 (18.7) 63.4 (20.4) 0.254
n (%) 34/39 (87.2) 96/117 (82.1)
Table 3 Summary of case mix, clinical course, and outcomes for
critically ill patients younger than 65 years old, stratified by frailty
status (Continued)
EQ-5D-VAS, 1-year
Mean (SD) 63.0 (20.2) 68.3 (17.6) 0.184
n (%) 28/37 (75.7) 85/113 (75.2)
MCIDc in EQ-5D-VAS
between 6 and 12 months,
n (%)
10/27 (37.0) 29/77 (37.7) 0.95
EQ-5D, 6-month, n (%)
Mobility 25 (71.4) 40 (41.2) 0.002
Self-care 11 (31.4) 8 (8.2) 0.001
Usual activities 30 (85.7) 65 (67.7) 0.041
Pain/discomfort 30 (85.7) 54 (55.7) 0.002
Anxiety/depression 19 (54.3) 36 (37.1) 0.077
ICU intensive care unit, ED emergency department, OR operating room, VAS
visual analogue scale, DNR do not resuscitate, APACHE Acute Physiology and
Chronic Health Evaluation, SOFA Sequential Organ Failure Assessment, EQ-5D
EuroQol Health Questionnaire, MCID minimal clinically important difference,
IQR interquartile range
aOther was defined as urologic/renal, neurologic, endocrinologic/metabolic,
hematologic/oncologic, trauma, musculoskeletal
bOther was defined as transfer from another hospital, other location
cMinimum difference of 7 points in the EQ-5D-VAS was considered clinically
important [13]
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(37.0 % vs. 37.7 %; p = 0.95) by 12 months. A greater
proportion of frail patients had problems across all
EQ-5D domains compared with those who were not
frail (Table 3).
Association between frailty and health services use
among nonelderly patients
There were no statistical differences in ICU or hospital
lengths of stay or rates of ICU readmission between frail
and nonfrail patients (Table 3). The hospital readmission
rate in the year following enrollment was significantly
greater for frail patients than for nonfrail patients.
Discussion
We performed a planned subgroup study to describe the
prevalence, as well as to characterize the correlates and
outcomes associated with frailty among a younger co-
hort of critically ill patients. Frailty has customarily been
described only among older persons; however, we believe
our study provides new knowledge and novel insights
into the occurrence and impact of frailty among younger
critically ill patients.
Main findings
First, we showed that frailty was relatively common
among younger patients admitted to the ICU in our
study, evident in more than one in four. This was signifi-
cantly greater than the estimated prevalence of frailty
Fig. 2 Adjusted survival probabilities by frailty status in intensive care unit (ICU) patients younger than 65 years old. Survival curves adjusted
for sex, Elixhauser comorbidity score, Acute Physiology and Chronic Health Evaluation II score, primary diagnostic criteria, and hospital type
(tertiary care/academic vs. community hospital)
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ond, as expected, several sociodemographic factors cor-
related with prehospital frailty. Frailty was more
common among women, those with less than a second-
ary school education, those receiving disability
insurance, and those requiring assistance at home. In
addition, in the 1-year period before the study, health
service use was higher among those classified as frail
than among those who were not frail. Third, frailFig. 3 Adjusted hazard rates of death stratified by frailty status in intensive
adjusted for sex, Elixhauser comorbidity score, Acute Physiology and Chron
type (tertiary care/academic v. community hospital)patients in this younger cohort where characterized by a
high burden of comorbid disease, in particular CTD and
heart failure (HF), and were prescribed a greater number
of medications than those who were not frail. Fourth,
preferences for life support, reasons for ICU admission,
and treatment intensity were similar between frail and
nonfrail patients. Finally, in adjusted analyses, long-term
mortality and rehospitalization were greater among
those with prehospital frailty.care unit (ICU) patients younger than 65 years old. Survival curves
ic Health Evaluation II score, primary diagnostic criteria, and hospital
Table 4 Crude and adjusted HR for death by Clinical Frailty Scale score categories in patients younger than 65 years old
CFS category Unadjusted HR 95 % CI p Value Adjusted HRa 95 % CI p Value
Fit (CFS score 1-3) 1.0 – – 1.0 – –
Vulnerable (CFS score 4) 3.67 1.55–8.69 0.003 2.89 1.19–7.02 0.019
Mild frailty (CFS score 5) 2.82 0.95–8.38 0.063 2.54 0.82–7.90 0.107
Moderate to severe frailty (CFS score 6–8) 4.93 1.91–12.73 0.001 4.41 1.62–12.06 0.004
CFS Clinical Frailty Scale
aAdjusted by sex, Elixhauser comorbidity score, Acute Physiology and Chronic Health Evaluation II score, primary diagnostic criteria, and hospital type
(tertiary care/academic vs. community hospital)
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Most published literature is focused on describing frailty
among older persons [12, 14, 15]; few authors have char-
acterized its epidemiology among nonelderly persons
[17], in particular in the context of critical illness [22].
This is likely attributable to most frailty research being
performed in the domain of geriatric medicine [6, 16]
and using administrative databases with age thresholds
(e.g., U.S. Medicare beneficiaries database) [14, 15] or
being based on the misconception that frailty is solely a
product of chronologic aging [12]. More recently,
researchers in a number of studies have evaluated the
prevalence and impact of frailty among specialized
cohorts of much younger patients, including lung trans-
plant candidates (median age 59 years [23]), end-stage
liver disease (mean age 55 years [24]), end-stage kidney
disease (mean age 55 years [25]), and kidney transplant
(mean age 53 years [26]). A greater rate of deficit accu-
mulation in selected younger persons may accelerate the
development of frailty, and, as such, these persons may
have “age-shifted” vulnerability to major stressors (i.e.,Fig. 4 Kaplan-Meier survival curves stratified by Clinical Frailty Scale (CFS) sco
care unit (ICU) patients younger than 65 years oldcritical illness) [27]. These patients manifest frailty and
“age” more rapidly relative to chronologic age [28]. Simi-
larly, the probability of survival after critical illness ap-
pears higher for younger than for older frail patients
[11]; however, younger patients may still experience a
longer and/or more complex post-ICU course and
recovery [29–32]. Accruing evidence, along with our
data, suggests that selected younger patients, such as
those with advanced chronic inflammatory diseases (e.g.,
CTD) or end-stage organ diseases (e.g., HF, cirrhosis)
may benefit from screening for frailty.
Comorbid disease and frailty are not mutually exclu-
sive and may show greater correlation among younger
patients with significant and/or advanced chronic illness
[1]. As examples, we identified both CTD and HF as
predictors of prehospital frailty. Few studies have evalu-
ated the prevalence and impact of frailty among patients
with CTD [33]. Numerous factors may predispose these
patients to frailty, including chronic disease progression
and persistent inflammation, disease-specific therapy
(i.e., immunosuppressive or other disease-modifyingre categories (fit, vulnerable, frail, moderate to severe frailty) in intensive
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exia), and sarcopenia [34]. Indeed, sarcopenia and nutri-
tional deficiencies before critical illness may amplify
early skeletal muscle loss in critical illness, further
prolonging recovery and exacerbating risk of incident or
worsening disability [35, 36]. Likewise, an estimated 18–
54 % of patients with HF are clinically frail [37]. Frailty
in HF may have important prognostic implications, in-
cluding reduced likelihood of self-management, impaired
HRQoL, greater hospitalizations, being declined for
transplant, and death [37, 38]. We believe our finding
of associations between frailty, selected comorbid con-
ditions, and critical illness requires confirmation and
evaluation in larger studies.
Prehospital frailty portends a greater risk of death
and impaired recovery following the stress of critical
illness. This finding would appear robust regardless of
age; however, there is likely some additive effect be-
tween frailty, older age, and risk of death [11, 12, 16].
Our study suggests that the association between
frailty and mortality may be attenuated in younger
compared with older patients; however, those with
moderate to severe frailty still exhibit significantly
higher risk [11]. This implies that frailty among youn-
ger patients may be less likely a terminal event or
imminent end-of-life trajectory. That said, these rela-
tively young frail survivors have greater opportunity
and time at risk for the multifarious physical (i.e., dis-
ability) and psychosocial (i.e., depression, posttrau-
matic stress, impaired HRQoL, inability to work, lost
income, social isolation) complications increasingly
described after critical illness [29–32, 39]. Indeed, at
6 months, frail survivors in our study described far
greater problems with mobility, self-care, usual activ-
ities, and pain. We found that more than half of frail
survivors described issues with depression and/or
anxiety [40]. Interestingly, despite all EQ-5D domains
being generally worse among frail patients, EQ-5D-
VAS scores, while impaired, were not significantly dif-
ferent at 6 and 12 months between frail and nonfrail
patients. Thus, frail survivors’ self-rated global
HRQoL was not significantly different from that of
those who were not frail. There may be a number of
explanations for these findings. First, it may imply
that frail survivors adapt with time to their new voca-
tion and/or disposition, despite the high prevalence of
residual “problems.” Second, this substudy may have
had limited capability to detect significant clinical dif-
ferences in HRQoL due to being relative small and
within the context of the operative features of the
EQ-5D. Regardless, this also translated into greater
rates of rehospitalization in the subsequent 1-year
period, implying greater health service use and
healthcare costs for those screened as frail [5].Implications for clinicians and future research
Our study has relevance for intensivists and all the other
clinicians who care for survivors of critical illness. It also
reinforces the potential value of frailty screening among
selected younger patients admitted to the ICU. Recogni-
tion and acknowledgement of prehospital frailty can
serve to inform survivorship expectations after critical
illness, as well as steer the mobilization of customized
recovery needs, both in the hospital and in the commu-
nity, across physical, emotional, and social domains [41].
The ideal content and implementation of multifactorial,
interprofessional post-ICU interventions to improve
recovery remain uncertain and a challenge for providers
[42, 43]. Importantly, we believe further rigorous research
in larger cohorts is needed to confirm our findings, to fur-
ther characterize those younger patients most likely to
benefit from frailty screening, and to develop translatable
interventions aimed at enhancing recovery (i.e., preserving
autonomy, slowing health status deterioration, societal re-
integration and engagement) and informing clinical
decision-making [13]. Moreover, future work should
ideally evaluate the comparative performance of additional
screening instruments in addition to the CFS score (e.g.,
frailty index, physical performance measures). In addition,
one of the most important implications of our work is that
future research related to recognizing and mitigating
frailty should not necessarily be age-restricted. Indeed, on
the basis of the importance of prior hospitalizations and
the presence of selected comorbid conditions, we believe
that the cohort of younger frail patients is only likely to
increase over time.
Limitations
Our study has important limitations that must be
considered. First, while the study was preplanned, we
recognize that it entails a secondary analysis focused
on a smaller subgroup with limited statistical power.
Second, while this study was focused on younger
critically ill patients, the age range for this subgroup
was still limited to patients aged 50–64.9 years. We
therefore cannot comment on the prevalence or im-
plications of frailty among those younger than 50 years
old. Third, we recognize that our study is susceptible
to selection bias, given that all participants were
recruited following ICU admission. Fourth, the CFS
score was intended as a screening tool for frailty that
was previously validated in older patients. We recognize
there is no “gold standard” for the diagnosis of frailty
among younger patients; however, we believe that the CFS
is simple, has face validity, and was able to discriminate a
subgroup at increased risk for adverse outcomes [6, 9].
We also did not capture additional highly correlated
surrogates for frailty, such as sarcopenia, that were shown
to have similar predictive capacity as measures of frailty
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[44]. Finally, as previously described [13], we did not
capture physical performance measures such as mobility,
grip strength, or cognition before critical illness, which
may have particular relevance among younger frail survi-
vors of critical illness.Conclusions
Frailty is common among younger critically ill patients
and predicts higher mortality, rates of rehospitalization
at 1 year among those who survive critical illness. Frailty
needs to be recognized and integrated into management
of selected younger patients admitted to the ICU, and
not just the elderly. A better understanding of the impli-
cations and outcomes associated with prehospital frailty
among younger critically ill patients will inform prog-
nostication; contribute to better-informed decision-
making; help to manage the survivorship expectations
for both patients and their families; and, importantly,
guide innovative research focused on interventions.Key messages
 Frailty was common among younger ICU patients,
being present in an estimated one-fourth of those
aged 50–64.9 years.
 Frail patients aged 50–64.9 years were more likely
to be female, to have greater comorbid illness
(in particular connective tissue disease), and to
have impaired baseline function and disability.
 Frail patients aged 50–64.9 years were more likely
to have been hospitalized in the 1-year period
preceding ICU admission.
 Frail patients aged 50–64.9 years had higher
adjusted mortality at 1 year and greater use
of healthcare services.Additional files
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